Status:
UNKNOWN
Five Year Oncological Outcome After CME for Right-sided Colon Cancer
Lead Sponsor:
Nordsjaellands Hospital
Collaborating Sponsors:
Bispebjerg Hospital
Hvidovre University Hospital
Conditions:
Colonic Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
Study based on existing databases investigating the causal oncological treatment effects of complete mesocolic excision on UICC stage I-III right-sided colon cancer.
Detailed Description
Population-based cohort study, predominantly prospective based, on the same population as the investigator's previously study comparing short-term outcome after CME with conventional colon resections....
Eligibility Criteria
Inclusion
- Right-sided colon cancer was defined as primary adenocarcinomas located in the cecum, ascending colon hepatic flexure, right or mid third of the transverse colon.
- UICC stage I-III - Gastroepiploic and infrapyloric lymph node metastases are not considered as distant metastases
Exclusion
- Synchronous colorectal cancer - even in the right colon
- No residual tumor in the specimen after neoadjuvant chemotherapy
- Metachronous colorectal cancer
- Appendix cancers
- Resections in Hillerød not performed according to the principles of CME
- Non-macroradical (R2) resections (peroperative assessment)
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 16 2019
Estimated Enrollment :
1069 Patients enrolled
Trial Details
Trial ID
NCT03754075
Start Date
June 1 2008
End Date
March 16 2019
Last Update
March 13 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.